Loading organizations...
The U.S. Department of Health and Human Services (HHS) serves as a principal federal agency, enhancing the health and well-being of all Americans. It delivers essential human services and fosters scientific advancements in medicine, public health, and social services. HHS administers various programs, from disease prevention to healthcare policy, leveraging federal strategy to protect national health.
HHS was established on April 11, 1953, as the Department of Health, Education, and Welfare. This unified federal public health, education, and social security responsibilities, based on cohesive governance essential for societal welfare. It became the Department of Health and Human Services in 1980, after education functions were separated, sharpening its focus solely on health and human services.
All American citizens benefit from HHS's extensive public health, medical research, and social support initiatives. The department’s vision: continuously improve the nation’s collective health and welfare. It achieves this through efficient program administration and scientific innovation, striving for a healthier, more secure future for the populace.
Key people at U.S. Department of Health and Human Services.
The U.S. Department of Health and Human Services (HHS) is not a company but a federal executive department responsible for protecting public health and providing essential human services to Americans.[1][2][5] Its mission is to enhance the health and well-being of all Americans through effective health and human services, while fostering advances in medicine, public health, and social sciences.[2][3][6] HHS oversees 11-13 operating divisions, including agencies like the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), Centers for Medicare & Medicaid Services (CMS), and others focused on research, disease prevention, food and drug safety, Medicare/Medicaid, and social support programs.[1][2][4][5][6] With a fiscal year 2025 budget of $1.06 trillion—the largest of any federal department—HHS administers over 300 programs, processes billions of health claims annually, and collaborates with state, local, and private entities to deliver services representing nearly a quarter of federal outlays.[4][5]
HHS traces its roots to 1980, when it was established by consolidating the Department of Health, Education, and Welfare (created in 1953) with functions split from the Department of Education.[5] Led by a Secretary appointed by the President and confirmed by the Senate, supported by a Deputy Secretary, it has evolved from focusing on basic public health and welfare to a comprehensive agency addressing modern challenges like pandemics, biomedical research, and health equity.[1][3] Key pivotal moments include expansions in Medicare/Medicaid administration, public health emergency responses, and a major 2025 restructuring that transferred the Administration for Strategic Preparedness and Response (ASPR) to the CDC to streamline biosecurity and response efforts.[1][4]
HHS stands out as the U.S. government's principal health agency through its scale, integration, and mandate:
HHS plays a pivotal role in health tech by regulating and funding innovations in biotech, digital health, and AI-driven public health tools amid trends like personalized medicine, telehealth expansion, and pandemic preparedness.[1][4] Its timing aligns with post-COVID demands for resilient supply chains, data interoperability, and rapid countermeasure development, bolstered by offices like the Assistant Secretary for Technology Policy promoting electronic health records and novel IT.[4] Market forces favoring HHS include rising chronic diseases, aging populations, and biotech investments, enabling influence over the ecosystem through FDA approvals, NIH grants, HRSA infrastructure support, and CMS reimbursement policies that shape private-sector adoption of health tech.[4][5][6]
HHS will likely deepen its tech integration by accelerating AI for disease forecasting, expanding health data exchanges, and leveraging 2025 restructurings for agile threat response amid climate-driven health risks and antimicrobial resistance.[1][4] Trends like value-based care and precision medicine will amplify its sway, potentially evolving it into a hub for public-private health tech partnerships. This positions HHS not as a startup player but as the foundational regulator and funder steering U.S. health innovation forward.[5]
U.S. Department of Health and Human Services has 4 tracked investments across 3 companies. The latest tracked deal is $9.0M Grant in Antheia in March 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 4, 2026 | Antheia | $9.0M Grant | U.S. Department OF Health And Human Services | — |
| Oct 3, 2024 | Sarvega | $17.5M Grant | U.S. Department OF Health And Human Services | — |
| Oct 14, 2020 | Cue Health Inc. | $481.0M Other Equity | U.S. Department OF Health And Human Services | — |
| Jul 12, 2018 | Cue Health Inc. | $30.0M Other Equity | U.S. Department OF Health And Human Services | Rohan OZA |
Key people at U.S. Department of Health and Human Services.